- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Menu
Menu
Menu
Menu
Menu
Brand Name :
Tice BCG, Tice BCG Vaccine, TheraCys
Synonyms :
Class :
Vaccine, Live (Bacterial)
Dosage Forms & Strengths
Solution- (reconstituted)
50mg
Dosage Forms & Strengths
suspension-(reconstituted)
50mg-Tice BCG
81mg-TheraCys
may enhance the risk of infection when combined with clobetasol propionate
when bcg vaccine is combined with melphalan the risk or severity of infection can be increased
may decrease the therapeutic effect of antibiotics
myelosuppressive agents may diminish the therapeutic effect of BCG
myelosuppressive agents may diminish the therapeutic effect of BCG
myelosuppressive agents may diminish the therapeutic effect of BCG
myelosuppressive agents may diminish the therapeutic effect of BCG
myelosuppressive agents may diminish the therapeutic effect of BCG
may enhance the adverse/toxic effect of BCG products
may enhance the adverse/toxic effect of BCG products
may enhance the adverse/toxic effect of BCG products
may enhance the adverse/toxic effect of BCG products
may enhance the adverse/toxic effect of BCG products
amoxicillin and clavulanate potassium
antibiotics decrease the efficacy of intravesical BCG
lansoprazole, amoxicillin, and clarithromycin
antibiotics decrease the efficacy of intravesical BCG
bismuth subcitrate, metronidazole and tetracycline
antibiotics decrease the efficacy of intravesical BCG
antibiotics decrease the efficacy of intravesical BCG
antibiotics decrease the efficacy of intravesical BCG
immunosuppressants increase the toxicity of BCG products
immunosuppressants increase the toxicity of BCG products
immunosuppressants increase the toxicity of BCG products
immunosuppressants increase the toxicity of BCG products
immunosuppressants increase the toxicity of BCG products
may decrease the therapeutic effect when combined with bcg
may decrease the therapeutic effect when combined with bcg
may decrease the therapeutic effect when combined with bcg
may have an increasingly adverse effect when combined with BCG products
may have an increasingly adverse effect when combined with BCG products
may have an increasingly adverse effect when combined with BCG products
may have an increasingly adverse effect when combined with BCG products
may have an increasingly adverse effect when combined with BCG products
may decrease the diagnostic effect when combined with hexaminolevulinate
may have an increasingly adverse effect when combined with BCG products
may have an increasingly adverse effect when combined with BCG products
may have an increasingly adverse effect when combined with BCG products
may have an increasingly adverse effect when combined with BCG products
may have an increasingly adverse effect when combined with BCG products
may have an increasingly adverse effect when combined with BCG products
piperacillin decreases the effectiveness of bcg vaccine by antagonism.
Therapeutic effects of the BCG vaccine can be decreased when interacting with cloxacillin.
Therapeutic effects of the BCG vaccine can be decreased when interacting with ticarcillin.
When bacampicillin combines with bcg vaccine, the effect of antitumor activity of the bcg vaccine gets reduces.
When penicillin G benzathine combines with bcg vaccine, the antitumor activity of vaccine decreases.
The therapeutic effects of the BCG vaccine can be decreased when interacting with azlocillin.
when both drugs are combined, there may be an increased risk or severity of infection
when both drugs are combined, there may be an increased risk or severity of infection
when both drugs are combined, there may be an increased risk or severity of infection
when both drugs are combined, there may be an increased risk or severity of infection
when both the drugs are combined, the risk or severity of infection increases
When both drugs are combined, there may be an increased risk or severity of infection can be increased
when both drugs are combined, there may be an increased risk or severity of infection
when both drugs are combined, there may be an increased risk or severity of infection
methotrexate may diminish the therapeutic effects of BCG vaccine
trimetrexate may diminish the therapeutic effects of BCG vaccine
when both drugs are combined, there may be an increased risk of developing an infection from the vaccine
trimetrexate may diminish the therapeutic effects of BCG vaccine
the risk of vaccine-associated infection may be increased
when both drugs are combined, there may be an increased risk of developing an infection from the vaccine
when both drugs are combined, the risk or severity of infection increases
when both drugs are combined, there may be an increased risk or severity of infection
when both drugs are combined, there may be an increased risk of developing an infection from the vaccine
when both drugs are combined, there may be a decreased therapeutic effect of the vaccine
when both drugs are combined, there may be a decreased therapeutic effect of the vaccine
the interaction decreases the therapeutic effects of the vaccine
the interaction decreases the therapeutic effects of the vaccine
When both drugs are combined, there may be a decreased therapeutic effect of the vaccine
the interaction decreases the therapeutic effects of the vaccine
the interaction decreases the therapeutic effects of the vaccine
when both drugs are combined, there may be an increased risk or severity of infection
it may reduce the therapeutic efficacy of the vaccine
it may reduce the therapeutical efficacy of the vaccine
lansoprazole amoxicillin and clarithromycin
when amoxicillin combines with bcg vaccine, it decreases the effects of action of vaccine by antagonism effect
amoxicillin and clavulanate potassium
when amoxicillin combines with bcg vaccine it decreases the effects of action of vaccine by antagonism effect
omeprazole amoxicillin and clarithromycin
when both drugs are combined, there may be a decreased effect of the drug's action on the vaccine by antagonism effect
when both drugs are combined, there may be a decreased effect of the drug's action on the vaccine by antagonism effect
may decrease the effect of each other
may increase the adverse effects
may enhance the immunosuppressive effect of immunosuppressants
may increase the toxic effect of immunosuppressants
may decrease the therapeutic effect of antibiotics
may decrease the therapeutic effect of myelosuppressive agents
may decrease the therapeutic effect of antibiotics
may increase the toxic effect of immunosuppressants
may decrease the therapeutic effect of antibiotics
may increase the toxic effect of immunosuppressive agents
may decrease the therapeutic effect of myelosuppressive agents
may decrease the therapeutic effect of myelosuppressive agents
may decrease the therapeutic effect of myelosuppressive agents
may decrease the therapeutic effect of myelosuppressive agents
neomycin/polymyxin B/gramicidin ophthalmic
may decrease the therapeutic effect of Antibiotics
may decrease the therapeutic effect of Myelosuppressive Agents
may decrease the therapeutic effect of Myelosuppressive Agents
may have an increasingly adverse effect when combined with BCG products
amoxicillin and clavulanate potassium
antibiotics may reduce the therapeutic effect of bcg Vaccine
lansoprazole, amoxicillin, and clarithromycin
antibiotics may reduce the therapeutic effect of bcg Vaccine
bismuth subcitrate, metronidazole and tetracycline
antibiotics may reduce the therapeutic effect of bcg Vaccine
antibiotics may reduce the therapeutic effect of bcg Vaccine
antibiotics may reduce the therapeutic effect of bcg Vaccine
may decrease the therapeutic effect when combined with BCG vaccine
may decrease the therapeutic effect when combined with BCG vaccine
may decrease the therapeutic effect when combined with BCG vaccine
may decrease the therapeutic effect when combined with BCG vaccine
may decrease the therapeutic effect when combined with BCG vaccine
may have an increased adverse effect when combined with BCG products
may have an increased adverse effect when combined with BCG products
may have an increased adverse effect when combined with BCG products
it may reduce the therapeutical efficacy of the vaccine
antibiotics decrease the effectiveness of the BCG vaccine
may decrease the therapeutic effect of antibiotics
imipenem/cilastatin/relebactam
may decrease the therapeutic effect of antibiotics
may decrease the therapeutic effect of antibiotics
may decrease the therapeutic effect of antibiotics
Adverse drug reactions:
Frequency Defined
>10%
Pain (17%)
Chills (9-34%)
Infection (2-18%)
Anemia (21%)
Flu-like syndrome (24-33%)
Malaise (7-40%)
Hematuria (26-39%)
Urinary urgency (6-18%)
Fever (17-38%)
Nausea/vomiting (3-16%)
Dysuria (52-60%)
1-10%
Abdominal pain (2-3%)
Headache (2%)
Rash (2-3%)
Genital inflammation /abscess (2%)
Renal toxicity (10%)
Hemorrhagic cystitis (9%)
Diarrhea (6%)
Leukopenia (6%)
Pregnancy warnings:
Pregnancy Category: C
Breastfeeding warnings:
crosses into breast milk- unknown
Pregnancy Categories:
Patient Information Leaflet
Generic Name: BCG vaccine live.
Why do we use the BCG vaccine live?
BCG vaccine live belongs to the class Vaccines, Live, Bacterial, which induces active immunity against Mycobacterium tuberculosis.
